Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technology of triazole and thiazide, applied in the field of medicine, can solve problems such as drug resistance or pharmacokinetic defects
Inactive Publication Date: 2015-09-23
SHIJIAZHUANG UNIVERSITY
View PDF5 Cites 2 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
[0004]Existing acetylcholinesterase inhibitors such as tacrine, stigmine, galantamine, etc., still have drug resistance or pharmacokinetic defects
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0020] Preparation of 5-(4-fluorophenyl)-3-mercapto-1,2,4-triazole
[0021] Add 9.1 g (0.1 mol) of thiosemicarbazide and 100 mL of dichloromethane into a 250 mL three-necked flask, stir and dissolve in an ice-water bath, and then add 10.3 g (0.13 mol) of pyridine. 20.6g (0.13mol) of 4-fluorobenzoyl chloride was slowly added dropwise at 0-5°C, and the dropwise addition was completed within 20 minutes. After 2 hours of reaction at 15°C, the reaction was terminated. A large amount of white solid appeared in the system and was filtered. Dissolve the obtained white solid in 80 mL of 5% sodiumhydroxide solution by mass fraction, heat to reflux for 2 hours, cool down to room temperature, adjust the pH to 5-6 with dilute hydrochloric acid with a mass fraction of 3.65%, a large amount of light yellow solid precipitates, filter , recrystallized to obtain 17.2 g of 5-(4-fluorophenyl)-3-mercapto-1,2,4-triazole, yield 88.2%, ESI-MS (m / z): 196.2(M +H) + .
Embodiment 2
[0023] Preparation of 5-(4-chlorophenyl)-3-mercapto-1,2,4-triazole
[0024] Thiosemicarbazide 9.1g (0.1 mol), dichloromethane 100 mL, pyridine 10.3g (0.13 mol) and 4-chlorobenzoyl chloride 22.75g (0.13mol) According to the method of Example 1, 5-(4-chloro Phenyl)-3-mercapto-1,2,4-triazole 18.3g, yield 86.7%, ESI-MS (m / z): 212.3(M+H) + .
[0027] Add 1.95g (0.01mol) of 5-(4-fluorophenyl)-3-mercapto-1,2,4-triazole and 2.47g (0.01mol) of 4'-chloro-3-bromopropiophenone in 50 mL of acetic acid was dissolved and refluxed for 3 hours. After the reaction was monitored by TLC, it was cooled to room temperature. The reaction solution gradually precipitated solids. After suction filtration, washing with water, and ethanol recrystallization, 2.15 g of white crystals were obtained, with a yield of 62.73%. 1 H-NMR (300MHz, DMSO), δ (ppm): 3.61 (H, d), 6.40 (H, t), 7.30 (2H, d, J =8.4Hz), 7.34(2H, d, J =8.4Hz), 7.44(2H, d, J =8.4Hz), 7.77(2H, d, J =8.4Hz); ESI-MS (m / z): 344.1 (M+H) + .
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
PUM
Login to View More
Abstract
The invention discloses a 5H-[1, 2, 4] triazole [5, 1-b] [1, 3] thiazide derivative with a general formula I, or a pharmaceutically acceptable aquo-complex and salts of the derivative; the derivative comprises a stereisomer or a tautomer, wherein R1 and R2 in the formula I are respectively independent hydrogen, methyl, halogen, hydroxyl, methoxyl, acetyl, propiono, nitro or alkoxy. The 5H-[1, 2, 4] triazole [5, 1-b] [1, 3] thiazide derivative has an obvious inhibiting effect on acetylcholin esterase, and is used for improving the memory of a patient suffering from dementia and Alzheimer's disease. The invention also relates to a preparation method of the compound and an application in preparation of a drug for treating Senile Dementia.
Description
technical field [0001] The invention belongs to the technical field of medicine, in particular to 5H-[1,2,4]triazolo[5,1-b][1,3]thiazine derivatives and their preparation methods and as acetylcholinesterase inhibitors , an application for improving memory in patients with dementia and Alzheimer's disease. Background technique [0002] Alzheimer's disease is associated with the degeneration of cholinergic neurons in the basal forebrain. As a result of said degeneration, patients suffering from this disease exhibit marked attenuations in acetylcholine synthesis, cholineacetyltransferase activity, acetylcholinesterase activity, and choline absorption. [0003] Acetylcholinesterase inhibitors are known to be effective in increasing cholinergic activity and thus may be used to improve memory in Alzheimer's disease patients. By inhibiting acetylcholinesterase, the compound increases levels of the neurotransmitteracetylcholine in the brain, thereby enhancing memory. [0004] T...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.